Recent years have witnessed groundbreaking advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://laytnwvqa394933.blogdomago.com/37620733/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide